|
TSPAN6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.26980003868039E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.38719990628556E-10 |
| Normal-vs-Stage2 |
2.05479999999536E-05 |
| Normal-vs-Stage3 |
5.479400E-03 |
| Normal-vs-Stage4 |
1.47279999995753E-06 |
| Stage1-vs-Stage2 |
8.892000E-01 |
| Stage1-vs-Stage3 |
4.294300E-02 |
| Stage1-vs-Stage4 |
7.875000E-01 |
| Stage2-vs-Stage3 |
1.303190E-01 |
| Stage2-vs-Stage4 |
9.609200E-01 |
| Stage3-vs-Stage4 |
7.822000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.1687999996487E-07 |
| Normal-vs-AfricanAmerican |
6.53059999966565E-07 |
| Normal-vs-Asian |
1.332800E-01 |
| Caucasian-vs-AfricanAmerican |
8.912200E-01 |
| Caucasian-vs-Asian |
3.759200E-01 |
| AfricanAmerican-vs-Asian |
1.345800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.28420002304597E-09 |
| Normal-vs-Female |
3.86220000000437E-05 |
| Male-vs-Female |
1.403500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.89259999999947E-06 |
| Normal-vs-Extreme_Weight |
1.20890000232521E-08 |
| Normal-vs-Obese |
3.7770000000048E-05 |
| Normal-vs-Extreme_Obese |
2.916700E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.379600E-02 |
| Normal_Weight-vs-Obese |
9.044400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.876200E-01 |
| Extreme_Weight-vs-Obese |
3.605900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.486780E-01 |
| Obese-vs-Extreme_Obese |
9.557800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.581670E-02 |
| Normal-vs-Age(41-60Yrs) |
6.91300000021933E-07 |
| Normal-vs-Age(61-80Yrs) |
1.0400000000077E-06 |
| Normal-vs-Age(81-100Yrs) |
2.259800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.187600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.942990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.708400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.999600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.860400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.265600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.46650000318627E-08 |
| Normal-VS-Type2 PRCC |
6.17579999999673E-05 |
| Normal-VS-KIRP CIMP |
4.157900E-02 |
| Normal-VS-Unclassified PRCC |
1.52340000003637E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.857220E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.062100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.013800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.116400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.349000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.180800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70159999979269E-07 |
| Normal-vs-N1 |
2.918300E-03 |
| Normal-vs-N2 |
1.028190E-01 |
| N0-vs-N1 |
5.101900E-02 |
| N0-vs-N2 |
3.836600E-01 |
| N1-vs-N2 |
9.038200E-01 |
|
|
